Company intelligence / Profile preview
Indus Life Sciences
- Ownership
- Private
- Development stage
- Other
Overview
Indus Life Sciences is a leading exporter and manufacturer of pharmaceutical and nutraceutical products, with strong recognition for quality, regulatory compliance, and international reach. Their pipeline products are commercialized and distributed across 40 countries, with awards for export excellence and innovative product launches (e.g., NUGEL)[1][3].
- Therapeutic areas
- Metabolic DisordersInfectious DiseasesGastroenterologyPulmonologyOther
- Modalities
- Small moleculeMineral supplementHerbal productVitamin supplement
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Indus Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Indus Life Sciences.